Andrew Schiff

Andrew Schiff

Fortune : 116 207 $ au 31/05/2026

60 ans
Health Technology
Health Services
Consumer Services

Profil

Dr. Andrew N.
Schiff
is a Non-Executive Chairman at Monte Rosa Therapeutics, Inc., an Independent Director at Aclaris Therapeutics, Inc., a Managing Partner at Aisling Capital LLC and a Chairman at Visiting Nurse Service of New York.
He is on the Board of Directors at Aclaris Therapeutics, Inc., Cempra Pharmaceuticals, Inc., Dren Bio, Inc., Henry Street Settlement, Inc., Planet Biopharmaceuticals, Inc. and Planet Technologies, Inc. Dr. Schiff was previously employed as an Independent Director by Agile Therapeutics, Inc., an Independent Director by ZELTIQ Aesthetics, Inc., a Board Observer by IQVIA RDS Asia, Inc., and a Clinical Assistant Professor-Medicine by NewYork-Presbyterian Hospital.
He also served on the board at Adams Respiratory Therapeutics, Inc., ArgiNOx Pharmaceuticals, Inc., Barrier Therapeutics, Inc., Bioenvision, Inc., CardioKine, Inc., Cempra, Inc., Colorescience Corp., Dynova Laboratories, Inc., F2G Ltd., Gilead Colorado, Inc., Harmony Biosciences Holdings, Inc., Miramar Technologies, Inc, PowerVision, Inc., Quintiles Transnational Holdings, Inc., Rycarma Therapeutics, Inc., Sirion Holdings, Inc., Sirion Therapeutics, Inc., SkinMedica, Inc., TransEnterix, Inc. /Old/ and Zavante Therapeutics, Inc. He received his undergraduate degree from Brown University, an MBA from The Trustees of Columbia University in The City of New York and a doctorate degree from Weill Cornell Medical College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
05/06/2026 25 540 ( 0,02% ) 116 207 $ 31/05/2026
11/06/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Andrew Schiff

SociétésPosteDébut
ACLARIS THERAPEUTICS, INC. Directeur/Membre du Conseil 09/08/2017
MONTE ROSA THERAPEUTICS, INC. Président 01/06/2023
Président -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 09/07/2010
Private Equity Investor 01/01/2000
Directeur/Membre du Conseil -

Anciens postes connus de Andrew Schiff

SociétésPosteFin
░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Voir l'expérience en détail de Andrew Schiff

Formation de Andrew Schiff

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

36

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées36

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Electronic Technology

Health Technology

Finance

Health Technology

Health Technology

Retail Trade

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Andrew Schiff